Jean-Charles Lambert chercheur
Lambert, Jeanne
Lambert, Jean-Charles, 1972-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 207213127 (Personal)
Permalink: http://viaf.org/viaf/207213127
Preferred Forms
-
100 0 _
‡a
Jean-Charles Lambert
‡c
chercheur
-
100 1 _
‡a
Lambert, Jean-Charles,
‡d
1972-....
-
100 1 _ ‡a Lambert, Jeanne
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Art et psychanalyse 1970-1983 : un parcours bibliographique |
|
| La confidentialité dans l'arbitrage international |
|
| Contribution à l'étude des facteurs de risque pour la maladie d'Alzheimer : analyse de candidats identifiés par étude d'association pangénomique ou GWAS |
|
| Étude de la fonction transcriptionnelle de la parkine dans les cancers cérébraux |
|
| Exploitation des données issues d'études d'association pangénomiques pour caractériser les voies biologiques associées au risque génétique du prolapsus de la valve mitrale |
|
| Genetic heterogeneity of Alzheimer's disease: complexity and advances |
|
| Genetics of venous thrombosis: insights from a new genome wide association study |
|
| A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly |
|
| Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes. |
|
| Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium |
|
| Genome-wide Association Study Links APOEϵ4 and BACE1 Variants with Plasma Amyloid β Levels |
|
| Genome-wide association study of kidney function decline in individuals of European descent |
|
| Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism |
|
| Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease. |
|
| Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis |
|
| A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis |
|
| Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk |
|
| GWAS for executive function and processing speed suggests involvement of the CADM2 gene. |
|
| High-Content Screening for Protein-Protein Interaction Modulators Using Proximity Ligation Assay in Primary Neurons |
|
| High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. |
|
| Identification de déterminants génétiques impliqués dans la composante vasculaire de la Maladie d'Alzheimer, par analyses transcriptomiques, génétiques et moléculaires |
|
| Identification of genetic factors of two intermediary phenotypes of the venous thromboembolism : the levels of factors VIII and von Willebrand. |
|
| Identification of the modulators of and the molecular pathways involved in the BIN1-Tau interaction |
|
| Implication of ADAM in pathophysiological process in Alzheimer's disease. |
|
| Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study |
|
| Independent and joint effects of the MAPT and SNCA genes in Parkinson disease |
|
| Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations--the ECTIM Study |
|
| Is the LDL receptor-related protein involved in Alzheimer's disease? |
|
| Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease? |
|
| KNG1 Ile581Thr and susceptibility to venous thrombosis |
|
| Leveraging genome-wide association studies data to inform the biology behind the genetic risk for mitral valve prolapse. |
|
| Mieux comprendre le gène PTK2B, un facteur de risque de la maladie d'Alzheimer, par l'utilisation de neurones dérivés de cellules souches pluripotentes induites humaines. |
|
| Mimic early phases of Alzheimer's disease by gene transfer. |
|
| miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer's disease |
|
| Mise en évidence d'une forme alternative de l'activateur tissulaire du plasminogène |
|
| Mon frère : vivre et vieillir avec son frère handicapé mental |
|
| Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease |
|
| Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy |
|
| Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms. |
|
| The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis? |
|
| A new GTP-cyclohydrolase I mutation in an unusual doparesponsive dystonia, familial form |
|
| No association of the HLA-A2 allele with Alzheimer's disease |
|
| Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study |
|
| A novel Alzheimer disease locus located near the gene encoding tau protein. |
|
| A Novel Genetic Marker for the C9orf72 Repeat Expansion in the Finnish Population |
|
| A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue |
|
| PLD3 and sporadic Alzheimer's disease risk. |
|
| A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer's disease |
|
| A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease. |
|
| A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain. |
|
| Probing the Alzheimer's disease risk gene PTK2B using human-derived induced neurons |
|
| Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease |
|
| The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects |
|
| Pyk2 overexpression in postsynaptic neurons blocks amyloid β<sub>1-42</sub>-induced synaptotoxicity in microfluidic co-cultures |
|
| Rare variants and exomes analyses : the example of Early-Onset Alzheimer Disease. |
|
| Recherche de déterminants génétiques susceptibles de moduler l'impact de l'apolipoprotéine E dans la maladie d'Alzheimer |
|
| Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins - role of the SH3 domain |
|
| A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis |
|
| Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer |
|
| The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels |
|
| Single polymorphism nucleotide rs1333049 on chromosome 9p21 is associated with carotid plaques but not with common carotid intima-media thickness in older adults. A combined analysis of the Three-City and the EVA studies |
|
| Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation |
|
| Study of the neuronal role of BIN1 genetic risk factor isoforms in Alzheimer's disease. |
|
| Study of the transcriptional function of parkin in brain cancers. |
|
| Study of thyroid hormone receptor alpha gene polymorphisms on Alzheimer's disease |
|
| TDP-43 loss-of-function causes neuronal loss due to defective steroid receptor-mediated gene program switching in Drosophila |
|
| Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides |
|
| Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease |
|
| Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's disease |
|
| Using High-Throughput Animal or Cell-Based Models to Functionally Characterize GWAS Signals |
|
| The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism |
|
| Variants rares et analyse d'exomes : application à la maladie d'Alzheimer du sujet jeune |
|
| Voxel-Based Statistical Analysis of 3D Immunostained Tissue Imaging |
|
| Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation |
|
